Regeneron Pharmaceuticals Inc.

In News

IFM Investors Pty Ltd Grows Stock Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

MarketBeat - Jul 09, 2025

Regeneron Pharmaceuticals, Inc. (REGN) Growth Story Shifts as Wells Fargo Maintains Hold - Yahoo Finance

Yahoo Finance - Jun 19, 2025

Regeneron Pharmaceuticals (REGN) Announces Approval of Dupixent in the US - Insider Monkey

Insider Monkey - Jul 06, 2025

US FDA approves Regeneron's blood cancer therapy - Reuters

Reuters - Jul 02, 2025

Rising Leaders 2025: Regeneron’s Karen Rodriguez Lorenc On Not Believing In Failure - insights.citeline.com

insights.citeline.com - Jul 09, 2025

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat

MarketBeat - Jul 08, 2025

Regeneron’s Lynozyfic Gains Accelerated FDA Approval for Multiple Myeloma - Yahoo Finance

Yahoo Finance - Jul 08, 2025

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Sold by Calamos Advisors LLC - MarketBeat

MarketBeat - Jul 08, 2025

UBS Lowers Price Target On Regeneron Pharmaceuticals, Inc. (REGN). - Yahoo Finance

Yahoo Finance - Jun 22, 2025

Teacher Retirement System of Texas Sells 5,855 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

MarketBeat - Jul 08, 2025

Regeneron Pharmaceuticals (REGN) and Sanofi Announce Approval of Dupixent® By US FDA - Yahoo Finance

Yahoo Finance - Jul 03, 2025

DekaBank Deutsche Girozentrale Purchases 9,969 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

MarketBeat - Jul 08, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.